Loading...
Loading...
also known as: Tesa/Ipa Blend, Visceral Fat GH Stack
Half-life: Per components
A dual GH peptide blend pairing Tesamorelin (visceral fat-targeting GHRH analog) with Ipamorelin (selective GHRP) for clean, targeted GH stimulation with emphasis on visceral fat reduction.
Mechanism of Action
Tesamorelin acts at GHRH receptors to stimulate GH release with particular efficacy against visceral fat; Ipamorelin synergizes by stimulating GH release through the ghrelin receptor.
AOD9604 adds direct β3-adrenergic fat mobilization independent of GH — complementary fat loss mechanism.
Already in this blend.
Already in this blend.
CJC-1295 and Tesamorelin serve similar GHRH roles — do not combine.
Graduate to the triple blend for enhanced GH stimulation after Tesa/Ipa cycle.
Storage
Refrigerate at 2–8°C (36–46°F).